Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
MRI contrast agents, especially gadolinium-based ones, can improve diagnostic accuracy but also carry potential health risks. Updated clinical recommendations emphasize careful patient selection, dose ...
A team led by Brent Wagner, MD, a professor in the University of New Mexico's School of Medicine Department of Internal Medicine, conducted a study published in the journal Magnetic Resonance Imaging.